A specific and direct comparison of the trifluoromethyl and pentafluoro sulfanyl groups on the selective dopamine D3 antagonist 3-(3-{[4-methyl-5-(4-methyl-1,3-oxazol-5-yl)-4H-1,2,4-triazol-3-yl]thio}propyl)-1-phenyl-3-azabicyclo[3.1.0]hexane template
Authors:
- Fabrizio MicheliFMFabrizio Micheli
- Daniele AndreottiDADaniele Andreotti
- Simone BraggioSBSimone Braggio
- Anna ChecchiaACAnna Checchia
- 1 August 2010
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 20 (15) , 4566-4568
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Triazolyl Azabicyclo[3.1.0]hexanes: a Class of Potent and Selective Dopamine D3 Receptor AntagonistsChemMedChem, 2010
- 1,2,4-Triazolyl Azabicyclo[3.1.0]hexanes: A New Series of Potent and Selective Dopamine D3Receptor AntagonistsJournal of Medicinal Chemistry, 2009
- Selective dopamine D3receptor antagonists. A decade of progress: 1997 – 2007Expert Opinion on Therapeutic Patents, 2008
- 1,2,4-Triazol-3-yl-thiopropyl-tetrahydrobenzazepines: A Series of Potent and Selective Dopamine D3Receptor AntagonistsJournal of Medicinal Chemistry, 2007
- Selective Dopamine D3 Receptor Antagonists: A Review 2001-2005Recent Patents on CNS Drug Discovery, 2006
- Recent advances towards the discovery of dopamine receptor ligandsExpert Opinion on Therapeutic Patents, 2006
- Dopamine D3 Receptor Partial Agonists and Antagonists as Potential Drug Abuse Therapeutic AgentsJournal of Medicinal Chemistry, 2005
- Design and Synthesis oftrans-3-(2-(4-((3-(3-(5-Methyl-1,2,4-oxadiazolyl))- phenyl)carboxamido)cyclohexyl)ethyl)-7-methylsulfonyl-2,3,4,5-tetrahydro- 1H-3-benzazepine (SB-414796): A Potent and Selective Dopamine D3Receptor AntagonistJournal of Medicinal Chemistry, 2003
- Pharmacological Actions of a Novel, High-Affinity, and Selective Human Dopamine D3 Receptor Antagonist, SB-277011-AThe Journal of Pharmacology and Experimental Therapeutics, 2000
- Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neurolepticsNature, 1990